appears to be a common phenomenon, present in the majority of individuals who are glucose intolerant, as well as a substantial proportion of an apparently healthy population.
There is a large body of evidence linking insulin resistance and compensatory hyperinsulinaemia to a cluster of abnormalities that increase the risk of CHD. This concept, first introduced in 1988 [3] , has since received considerable experimental support [7] [8] [9] , and the number of abnormalities associated with insulin resistance, compensatory hyperinsulinaemia, and CHD has grown substantially [10] .
Insulin resistance and compensatory hyperinsulinaemia play a central role in the regulation of lipoprotein metabolism [11] , and the dyslipidaemia resulting from these abnormalities suggests one explanation for a link between insulin metabolism and CHD. Resistance to insulin-mediated glucose disposal and compensatory hyperinsulinaemia correlate strongly with VLDL-TG secretion rate and plasma TG concentration in both hypertriglyceridaemic and normotriglyceridaemic individuals [12] [13] [14] [15] . Experimental manipulations which modify insulin action and/or plasma insulin concentration lead to predictable changes in VLDL-TG secretion rate and plasma TG concentration. For example, weight loss is associated with an increase in insulin-stimulated glucose uptake and decreases in plasma insulin concentration, hepatic VLDL-TG secretion, and plasma TG concentration [16] . In contrast, ingestion of a high carbohydrate diet leads to day-long parallel increases in plasma insulin and TG concentrations [17] .
Once the plasma VLDL-TG pool-size increases. associated abnormalities of plasma lipoprotein metabolism develop. The best established of these is low high density lipoprotein (HDL)-cholesterol concentration [18] . When insulin-mediated glucose uptake is quantified in normal volunteers, the subset that is most insulin resistant has the highest insulin and TG and lowest HDL-cholesterol concentrations [19] . The associations of insulin resistance with plasma TG and HDL-cholesterol concentrations are independent of obesity, either general or abdominal, and level of aerobic fitness as estimated by maximal oxygen consumption [19] .
In addition to a low HDL-cholesterol, hypertriglyceridaemia is associated with two other important changes in lipoprotein metabolism that increase the risk of CHD: small, dense LDL-particles [20] and the accentuation of postprandial lipaemia [21] . Whether or not these changes are directly due to insulin resistance and compensatory hyperinsulinaemia, or simply secondary to the hypertriglyceridaemia that develops in subjects who are insulin resistant and hyperinsulinaemic, is not clear. However, we have recently shown that among 100 normal subjects, those with small, dense LDL particles are relatively insulin resistant, glucose intolerant, hyperinsulinaemic, hypertensive, hypertriglyceridaemic and have a lower HDL-cholesterol concentration [22] . We are not aware of any data in non-diabetic subjects demonstrating an association between insulin resistance, hyperinsulinaemia, and postprandial lipaemia, but we have shown such an association in patients with non-insulin-dependent diabetes mellitus [23] .
The lipid abnormalities related to insulin resistance and compensatory hyperinsulinaemia are known to increase the risk of CHD. The strong association of low HDL-cholesterol to CHD risk has been shown in numerous studies [24] [25] [26] [27] . In contrast, controversy continues as to whether or not hypertriglyceridaemia is an "independent" risk factor for CHD. Although high plasma TG and CHD are strongly correlated in univariate analysis, the relationship between hypertriglyceridaemia and CHD often loses statistical significance in multivariate analyses when variations in plasma HDL-cholesterol and glucose are taken into consideration [28] [29] [30] [31] . However, as pointed out previously, plasma glucose, insulin, TG and HDL-cholesterol concentrations are themselves highly correlated. The problems with performing multivariate analysis to ascertain which of a series of variables is "independently" related to CHD, when the measures are themselves highly correlated, have recently been emphasized [30] . We have suggested previously that the examination of the contribution of this cluster of risk factors to CHD rather than the independent contribution of each variable may be the more appropriate analysis [32] . Furthermore, recent reports examining the contributions of HDL cholesterol and triglycerides to risk for atherosclerotic vascular disease showed the highest risk in men with low HDL cholesterol and high triglyceride concentrations [26, 27] . Similarly, in the initial report demonstrating the increased risk for CHD associated with small, dense LDL cholesterol, it is notable that subjects with 949 this lipoprotein abnormality had relatively low HDL cholesterol and high triglyceride concentrations [20] , again demonstrating the cluster of metabolic abnormalities.
There is evidence that insulin resistance and compensatory hyperinsulinaemia are associated with changes that accentuate thrombosis formation by increasing coagulation and inhibiting fibrinolytic processes [9, 33 35] . For example, plasminogen activatorinhibitor-1 (PAI-1) is associated with recurrent myocardial infarction in younger men, and is strongly inversely correlated with insulin and triglyceride concentrations, and directly correlated with insulin resistance [9, [33] [34] [35] [36] . Since insulin resistance, hyperinsulinaemia, and hypertriglyceridaemia are themselves highly correlated [3, [12] [13] [14] [15] , it is not clear which of these changes is most important in regulation of PAI-1 levels. However, these observations provide further support for the role played by insulin resistance and hyperinsulinaemia in the pathogenesis of CHD.
Although no one would argue with the statement that CHD is the major cause of morbidity and mortality in patients with high blood pressure, many individuals, including Prof. Jarrett [37] , would argue that insulin resistance and compensatory hyperinsulinaemia have nothing to do with the aetiology or clinical course of patients with hypertension. We would agree that not all patients with high blood pressure are insulin resistant and hyperinsulinaemic. We are also aware that not all epidemiologic studies show a correlation between plasma insulin con~ centration and blood pressure. On the other hand, neither of these observations prove that insulin resistance and compensatory hyperinsulinaemia are unrelated to either the aetiology and/or clinical course of a substantial portion of patients with high blood pressure.
Patients with high blood pressure, as a group, are resistant to insulin-mediated glucose uptake and hyperinsulinaemic when compared to a closely-matched population with normal blood pressure [38] . These abnormalities persist despite successful drug treatment of hypertension, and can be seen in both obese and non-obese individuals [38] . Furthermore, abnormalities of insulin metabolism can be discerned in normotensive first degree relatives of patients with high blood pressure [39, 40] , but not in patients with secondary forms of hypertension [41] . The fact that insulin resistance and hyperinsulinaemia can be demonstrated in patients at risk for the development of hypertension raises the possibility that these abnormalities may play a role in the regulation of blood pressure. Further support for the view that insulin resistance and compensatory hyperinsulinaemia are involved in blood pressure regulation can be found in studies of rodent hypertension. Substitution of fructose for the carbohydrate conventionally present in rat chow leads to insulin resistance, hyperinsulinaemia and hypertension in Sprague-Dawley rats [42] . Subsequent studies in fructose-fed rats have shown that fructose-induced hypertension can be markedly attenuated if either insulin resistance and/or hyperinsulinaemia are prevented by either exercise training fructose-fed rats [43] or by chronically infusing somatostatin [44] . Hyperinsulinaemia has also been demonstrated in rats with genetic hypertension-including the spontaneously hypertensive rat, the Dahl saltsensitive rat, and the Milano hypertensive rat [45] [46] [47] . Furthermore, resistance to insulin stimulated glucose uptake has been demonstrated in adipocytes isolated from spontaneously hypertensive and Dahl salt-sensitive rats [45, 46] . Two major arguments have been advanced against the view that insulin resistance and hyperinsulinaemia are involved in blood pressure regulation. The first is that acute hyperinsulinaemia produced by infusing insulin intohumans leads to vasodilation, and blood pressure does not increase [48] . In addition, blood pressure does not change when insulin is infused into dogs for periods of up to 2 weeks [49] . However, blood pressure does increase when rats are infused with insulin [50] . A second argument is that a relationship between insulin level and blood pressure cannot always be seen in population studies. For example, a recent report has shown that blood pressure and insulin concentration were significantly correlated in Caucasians, but not in Afro-Americans or Pima Indians [51] . However, other studies have shown that hypertensive Afro-Americans are insulin resistant and hyperinsulinaemic when compared to Afro-Americans with normal blood pressure [52, 53] , raising obvious questions as to the significance of the lack of a relationship between blood pressure and insulin described in Afro-Americans in epidemiological studies [51] .
The role of insulin resistance and compensatory hyperinsulinaemia in the clinical course of patients with high blood pressure appears to be less controversial. In the first place, these subjects tend to be glucose intolerant, and there is certainly evidence that this abnormality would increase their risk of CHD [3, 38, 54, 55] . In addition, hyperglyceridaemia is commonly seen in patients with essential hypertension and in their first-degree relatives [38] [39] [40] , as well as in dietary-induced and genetic forms of rodent hypertension [42] [43] [44] [45] [46] [47] . The association between insulin resistance and compensatory hyperinsulinaemia in the development of hypertriglyceridaemia, as well as the relationship between an increase in plasma TG concentration and CHD, have already been discussed, and it should not be necessary to repeat at this juncture. Further bolstering the link between abnormal insulin metabolism, high blood pressure, and CHD is the recent observation that patients with high blood pressure and ECG evidence of CHD were insulin resistant G. M. Reaven: Insulin resistance and hyperinsulinaemic when compared to a matched group of patients with high blood pressure who did not demonstrate ischaemic ECG changes [56] . In light of these considerations, we would suggest that there is ample evidence that the development of CHD in patients with hypertension may be secondary to the defects in insulin metabolism that exist in these subjects.
There is now abundant evidence from both epidemiological and case-control studies that insulin resistance and/or hyperinsulinaemia, dyslipidaemia, hypertension and defects in haemostatic function cluster in individuals [3, 7-19, 31-35, 38-40, 52, 53] . In this brief presentation we have tried to summarize evidence that resistance to insulin-mediated glucose disposal and compensatory hyperinsulinaemia predispose individuals to develop this cluster of associated abnormalities that increase the risk of CHD. Although we have cast the abnormalities of insulin metabolism in a central role, we are aware that questions remain to be answered regarding the relationship between the metabolic, haemodynamic, and haemostatic abnormalities associated with insulin resistance and compensatory hyperinsulinaemia; issues that we cannot address within the constraints of this presentation. However, despite these unresolved questions, we think available information strongly supports the view that resistance to insulin-mediated glucose uptake, and its consequences, are involved to a substantial degree in the cause and clinical course of CHD. 
